Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous Injection in China
- Written by PR Newswire
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) in China. This is an investigational ophthalmic drug developed by the group's subsidiary...